Navigation Links
Cobalis Reports Phase III Trial Results for PreHistin in Seasonal,Allergic Rhinitis

ck the symptom-causing effects of histamine may be eliminated, or minimized. PreHistin is patented for the treatment of atopic allergic diseases such as seasonal and perennial allergies, dermatitis, migraine, food allergies and asthma.

About Cobalis Corp.

Cobalis Corp. is a specialty pharmaceutical development company specializing in medications to prevent and treat atopic disease, including allergies, migraine headache, atopic asthma and dermatitis. Its flagship drug candidate PreHistin is an allergy medication in Phase III clinical development. For further information, visit www.cobalis.com

Safe Harbor Statement: This press release contains forward-looking statements for purposes of the Private Securities Litigation Reform Act of 1995 (the "Act"). Cobalis disclaims any intent or obligation to update these forward-looking statements, and claims the protection of the Safe Harbor for forward-looking statements contained in the Act. Examples of such statements include, but are not limited to, any statements relating to the timing, scope or expected outcome of the Company's clinical development of its drug candidates, the potential benefits of the Company's drug candidates and the size of the potential market for the Company's products. Such statements are based on management's current expectations, but actual results may differ materially due to various factors. Such statements involve risks and uncertainties, including, but not limited to, those risks and uncertainties relating to securing funding for ongoing operations including clinical trials, difficulties or delays in development, testing, regulatory approval, production and marketing of the Company's drug candidates, unexpected adverse side effects or inadequate therapeutic efficacy of the Company's drug candidates that could slow or prevent product approval or market acceptance (including the risk that current and past results of clinical trials are not necessarily indicative of future resu
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Cobalis Expects to Report Phase III Top-Line Results in May
2. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
3. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
4. Cytos Biotechnology Reports Results from Phase IIa Study with CYT003-QbG10 in Patients Suffering from Atopic Dermatitis
5. Cytokinetics Reports Additional Clinical Trials Data for Ispinesib
6. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
7. Cytochroma Reports Positive Phase I Clinical Data for CTA018 Injection
8. Speedel Reports Successful SPP635 Phase IIa Trial in Hypertension
9. Columbia Laboratories Reports Positive Results from Multi-dose Pharmacokinetic Study of Vaginally-administered Lidocaine
10. CytRx Reports Promising Data from Its Open-Label Extension Clinical Trial of Arimoclomol in ALS
11. Affymax Reports Phase 2 Clinical Dose Ranging Results of Once-Per-Month Hematide for the Treatment of Anemia
Post Your Comments:
(Date:6/17/2013)... 2013 Velplex, LLC announced this week that ... that connects buyers and sellers of discount dental ... Why? It,s because the business leaders ... with the dental industry. They have 50 years of ... worked to negotiate some of the best prices in ...
(Date:6/17/2013)... , June 17, 2013 Vanda ... presented additional data today at ENDO 2013, the ... that tasimelteon can entrain (synchronize) both melatonin and ... to reset the master body clock and address ... Disorder (Non-24).  The SET (Safety and Efficacy of ...
(Date:6/17/2013)...  Hanger, Inc. (NYSE:  HGR) today announced the signing ... senior secured facilities to an aggregate of up to ... agreement includes a $200 million revolving credit facility and ... agreement was comprised of a $100 million revolving credit ... facility matures on June 17, 2018, and is subject ...
Breaking Medicine Technology:TopProdeals.com Rises to Top as Discount Dental Supply Leader 2Vanda Presents Data From Phase III Studies that Demonstrate Tasimelteon Restores Daily Cortisol Rhythm In Blind Patients With Non-24-Hour Disorder 2Vanda Presents Data From Phase III Studies that Demonstrate Tasimelteon Restores Daily Cortisol Rhythm In Blind Patients With Non-24-Hour Disorder 3Vanda Presents Data From Phase III Studies that Demonstrate Tasimelteon Restores Daily Cortisol Rhythm In Blind Patients With Non-24-Hour Disorder 4Hanger Enters New 5-Year Credit Agreement to Refinance Senior Secured Credit Facilities 2Hanger Enters New 5-Year Credit Agreement to Refinance Senior Secured Credit Facilities 3
... 2011 Watson Pharmaceuticals, Inc. (NYSE: ... has received U.S. Food and Drug Administration ("FDA") ... for Enoxaparin Sodium Injection in the 100mg/mL and ... equivalent to Sanofi-aventis, LOVENOX®, and is a low ...
... SYDNEY, Sept. 19, 2011 HeartWare International, Inc. (NASDAQ: ... innovator of less invasive, miniaturized circulatory support technologies that ... announced that CEO Doug Godshall is scheduled to present ... Device Day at 1:55 p.m. ET on Thursday, September ...
Cached Medicine Technology:Watson Pharmaceuticals Announces Approval of Amphastar's Generic LOVENOX(R) 2Watson Pharmaceuticals Announces Approval of Amphastar's Generic LOVENOX(R) 3HeartWare to Present at The Lazard Capital Markets 3rd Annual Circulatory Assist Device Day 2
(Date:6/17/2013)... Cell Institute (HSCI) researchers have identified in the most ... embryonic stem cell self-renewal, beginning a creative search for ... gene, SALL4, gives stem cells their ability to continue ... Typically, cells only express SALL4 during embryonic development, but ... acute myeloid leukemia and 10 to 30 percent of ...
(Date:6/17/2013)... The Woodstock Fruit Festival is proud to extend an ... which will be held in Diamond Point, New York from ... professes the benefits he's received by regularly eating up ... class sprinting abilities. Fruit is commonly considered health food, but ... Blake believes in the power of natural foods, and the ...
(Date:6/17/2013)... 2013 MelanSol® All Natural Skin Care ... the US distributor for MelanSol®, has partnered with the ... Food Bank to support their efforts to feed ... that they receive a portion of every sale of ... Moisturizer. Contributions will be given on sales from ...
(Date:6/17/2013)... YORK, NY (June 17, 2013) A team from ... and the Naomi Berrie Diabetes Center of Columbia University ... accurately reflect the features of maturity-onset diabetes of the ... of MODY patients to produce induced pluripotent stem (iPS) ... into a mouse, the stem cell-derived beta cells secreted ...
(Date:6/17/2013)... Tarrant Plastic Surgery is pleased to announce a summer mommy ... undergone a mainstream culture explosion. Interpretation of the term may ... regard the term to mean a combination of breast and ... effects of pregnancy on a woman’s body. , Effects ... with gain or loss of volume, widening of the nipple ...
Breaking Medicine News(10 mins):Health News:A new target for cancer drug development 2Health News:Yohan Blake Invited to The Woodstock Fruit Festival as Guest of Honor 2Health News:All Natural Sunscreen Fights Hunger 2Health News:NYSCF and Columbia researchers demonstrate use of stem cells to analyze causes, treatment of diabetes 2Health News:NYSCF and Columbia researchers demonstrate use of stem cells to analyze causes, treatment of diabetes 3Health News:Tarrant Plastic Surgery Announces Summer Makeover Special 2
... Boston Scientific Corporation (NYSE: BSX ) ... Company 29th Annual Health Care Conference.Jim Tobin, Chief Executive ... 17th, beginning at approximately 3:55 p.m. E.T. Following ... Financial Officer will join Mr. Tobin in a question ...
... 10 Representatives Gene Green (D-TX), Ed Whitfield (R-KY), ... Mike Rogers (R-MI), Betty Sutton (D-OH), Bart Gordon (D-TN), ... H.R. 1392. This bill will amend title XVIII of ... amounts for drugs and biologicals under Part B of ...
... , , GEORGETOWN, Texas, March 10 ... provider, ranked 21st overall in the recent Dun & ... Clips is listed as the highest-ranked, fastest-growing hair-care franchise ... AllBusiness.com "Top 10 Franchises for Veterans." ...
... Coronado, Washington Four Seasons and seven additional hotels join ... Luxury hotel owner, Strategic Hotels, today announced that ... UNICEF-supported clean water campaign known as the Tap ... award-winning, lifesaving initiative helps UNICEF provide clean water to ...
... are highlights from the March issue of Mayo ... as often as you wish. Mayo Clinic ... Reprinting is allowed for a fee. Include the following ... www.bookstore.mayoclinic.com or call toll-free for subscription information, 800-876-8633, ...
... Ltd. announced today that OAD Orthopaedics of Warrenville, Illinois, has ... is designed to save precious clinical time for busy ... seeing large volumes of patients each day. When a ... a reader, and the images for that patient are instantly ...
Cached Medicine News:Health News:House Bill to Improve Accuracy of Medicare Reimbursement Introduced: Members of Congress Seek to Stem Growing Healthcare Coverage Shortfalls, Community Oncology Alliance Advocates for Swift Passage of Bill 2Health News:House Bill to Improve Accuracy of Medicare Reimbursement Introduced: Members of Congress Seek to Stem Growing Healthcare Coverage Shortfalls, Community Oncology Alliance Advocates for Swift Passage of Bill 3Health News:Sport Clips Tops Hair-care Franchises in '2009 AllBusiness AllStars' 2Health News:Tap Project Partners With Strategic Hotels for 2009 UNICEF Clean Water Campaign 2Health News:Tap Project Partners With Strategic Hotels for 2009 UNICEF Clean Water Campaign 3Health News:March 2009 Mayo Clinic Women's HealthSource Highlights Molecular Breast Imaging, Canes and Walkers, Training for an Event and Hormone Therapy for Women 2Health News:March 2009 Mayo Clinic Women's HealthSource Highlights Molecular Breast Imaging, Canes and Walkers, Training for an Event and Hormone Therapy for Women 3Health News:March 2009 Mayo Clinic Women's HealthSource Highlights Molecular Breast Imaging, Canes and Walkers, Training for an Event and Hormone Therapy for Women 4Health News:March 2009 Mayo Clinic Women's HealthSource Highlights Molecular Breast Imaging, Canes and Walkers, Training for an Event and Hormone Therapy for Women 5Health News:March 2009 Mayo Clinic Women's HealthSource Highlights Molecular Breast Imaging, Canes and Walkers, Training for an Event and Hormone Therapy for Women 6Health News:'Swipe Card, See Image': OAD Orthopaedics Improves Clinical Workflow with OrthoFlow 2
... The model 55S Rocking Shaker provides ... and blotted membranes. The very slow ... degree of tilt provide a gentle ... over gels and blotted membranes to ...
Plate Roller...
Conversion Kits For Modular Incubator Chamber...
Multi-Tier Shaker...
Medicine Products: